Aug 15
Opportunity
Participants expect a simple and convenient experience participating on clinical trials. To accomplish this goal, sponsors should consider the type, design and delivery of device (e.g., personal device, provided by study, etc.) for participants to achieve accessibility, flexibility, convenience and maintain privacy.
Considerations to Help Action the Opportunity
- Understand if the clinical trial design supports the applications of digital patient solutions
- Understand the needs and preferences of the participants taking part in the trial
- Does the population have access to devices and data plans, or would they need these to be provisioned?
- What devices would participants already have that could be used for clinical trials (e.g., wearables / sensors, glucometers, weighing scales, phones / tablets, etc.)?
- Understand impact on health equity (i.e., geographic, socioeconomic barriers) when implementing digital solutions
- Partner with sites to gain their input on the impact of multiple services, training, and technology implementation
- Understand how the device may impact data integrity, regulatory landscape, site implementation and overall costs
- Define how technology is designed, communicated and delivered for / to participants
- Define backup options (e.g., when a participant is unable to connect to device)
Value and Potential Benefits
- Increases access and ease of participation for participants on clinical trials by potentially reducing the number of site visits
- Allows for more robust datasets with improved data compliance and quality by enabling direct entry and near real-time review of data
Related Blog Posts
A Toolkit for ICH-E6(R3)
Released at the start of 2025, the ICH-E6(R3) guideline is an updated international standard for how clinical trials should be designed, conducted, recorded, and reported. At its core, the guideline ensures that people who participate in clinical trials are kept safe and that the data collected is reliable and meaningful. This guideline is not a…
Expanding clinical trial access through technology, support
Clinical trials are a key tool for producing the safety and efficacy data that guide new therapies to market. Progress in clinical research relies on those who volunteer to participate, and yet, access to trials is not the same for everyone in the United States. Read the full article featuring Allison Cuff Shimooka from TechTarget…
Good Clinical Practice has Changed: Are You Ready for ICH-E6(R3)?
ICH-E6(R3) represents a shift in mindset when it comes to clinical trials. Rather than trying to control every part of a trial equally, the guideline wants researchers to focus most on factors that are critical to participant safety and the reliability of trial results. It introduces the idea of “proportionality,” meaning more control is applied…
